CIK 0001855485 · <br>Emerging growth company
Calidi Biotherapeutics, Inc.
Sign in to watch- Tickers
- CLDI CLDWW
- Exchange
- NYSE, OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862967193
- Phone
- 858-794-9600
- Business address
- 4475 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Calidi Biotherapeutics, Inc., First Light Acquisition Group, Inc.
Securities
- CLDI Calidi Biotherapeutics, Inc. Common Stock NYSE
- CLDWW Common stock OTC
- 8-K Event Results of operations · Regulation FD disclosure
- 10-K Report Annual Report
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K/A Event Exhibits
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 424B5 Offering Prospectus
- 8-K Event Other events
- 8-K Event Agreement ended · Results of operations · Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Grant or award Director acquired 12,771 shares (grant or award)
- 4 Grant or award Director acquired 11,684 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 6 of 21 · 406 filings